English: Llywydd, the Member is quite wrong in his description of the position in north Wales. By 8 a.m. yesterday, 31,095 citizens in north Wales had been vaccinated, and that is by some way the highest number of any health board anywhere in Wales. So, far from being held back, actually, the actions of the Betsi Cadwaladr health board are putting them in the lead of vaccination here in Wales. And that is because of the amazing response that we have had from the GP community and the community pharmacy community in north Wales. All 98 primary care practices in Betsi Cadwaladr have indicated that they wish to engage and deliver the AstraZeneca vaccine. Now, Darren Millar is right that we had hoped to receive 26,000 more doses of the Oxford vaccine than will come our way this week. And that has meant that some plans that were there in north Wales to accelerate still further vaccination have had to be held back. The good news is that the UK Government assure us that we will get that supply next week, in addition to what we were already expecting next week. So that will be a very temporary downturn in the vaccine that we would otherwise expect. GPs in their own surgeries are much better equipped to deliver the Oxford vaccine than the Pfizer vaccine, for reasons that many Members will know. The Pfizer vaccine has to be stored in very particular conditions, not simply of temperature but in other conditions as well. It means the Pfizer vaccines are suited for the mass vaccination centres - three of them already in north Wales - and for the hospital-based vaccination centres - three of those in north Wales - and the GP community will focus on the AstraZeneca-Oxford vaccine. The success of that strategy lies behind the very considerable success that we are seeing in north Wales and which I know the Member will want to recognise and to celebrate.
Welsh: Llywydd, mae'r Aelod yn hollol anghywir yn ei ddisgrifiad o'r sefyllfa yn y gogledd. Erbyn 8 a.m. ddoe, roedd 31,095 o ddinasyddion yn y gogledd wedi cael eu brechu, a dyna'r nifer uchaf o gryn dipyn o unrhyw fwrdd iechyd yn unman yng Nghymru. Felly, ymhell o gael eu dal yn ôl, mewn gwirionedd, mae gweithredoedd bwrdd iechyd Betsi Cadwaladr yn eu rhoi ar y blaen o ran brechu yma yng Nghymru. Ac mae hynny oherwydd yr ymateb anhygoel yr ydym ni wedi ei gael gan y gymuned meddygon teulu a'r gymuned fferylliaeth gymunedol yn y gogledd. Mae pob un o'r 98 practis gofal sylfaenol yn Betsi Cadwaladr wedi nodi eu bod nhw'n dymuno cymryd rhan a darparu brechlyn AstraZeneca. Nawr, mae Darren Millar yn iawn ein bod ni wedi gobeithio cael 26,000 yn fwy o ddosau o frechlyn Rhydychen nag y byddwn ni'n eu derbyn yr wythnos hon. Ac mae hynny wedi golygu bod rhai cynlluniau a oedd yno yn y gogledd i gyflymu brechu ymhellach fyth wedi gorfod cael eu dal yn ôl. Y newyddion da yw bod Llywodraeth y DU yn ein sicrhau y byddwn ni'n cael y cyflenwad hwnnw yr wythnos nesaf, yn ogystal â'r hyn yr oeddem ni eisoes yn ei ddisgwyl yr wythnos nesaf. Felly, bydd hynny'n ostyngiad dros dro iawn i'r brechlyn y byddem ni'n ei ddisgwyl fel arall. Mae meddygon teulu yn eu meddygfeydd eu hunain mewn sefyllfa well o lawer i ddarparu brechlyn Rhydychen na'r brechlyn Pfizer, am resymau y bydd llawer o Aelodau yn ymwybodol ohonynt. Mae'n rhaid storio'r brechlyn Pfizer mewn amodau penodol iawn, nid yn unig o ran tymheredd ond o ran amodau eraill hefyd. Mae'n golygu bod brechlynnau Pfizer yn addas ar gyfer y canolfannau brechu torfol - mae tri ohonyn nhw yn y gogledd eisoes - ac ar gyfer y canolfannau brechu mewn ysbytai - tri o'r rheini yn y gogledd - a bydd y gymuned meddygon teulu yn canolbwyntio ar frechlyn AstraZeneca-Rhydychen. Llwyddiant y strategaeth honno yw sail y llwyddiant sylweddol iawn yr ydym ni'n ei weld yn y gogledd ac y gwn y bydd yr Aelod eisiau ei gydnabod a'i ddathlu.